Does an antibiotic stewardship programme reduce medication adherence in pregnant women? A multicentre observational study
Published
August 7, 2025
Paper ID
PAP-000188
Status
Published
DOI
10.65712/tmj.test000446
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on an antibiotic stewardship programme. Methods: We conducted a multicentre observational study across 8 centres between 2016 and 2024. Results: medication adherence occurred in 11% of the intervention group versus 32% of controls. medication adherence occurred in 20% of the intervention group versus 22% of controls. Conclusion: Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial.
Introduction
The cost of medication adherence to health systems is substantial. Earlier studies of an antibiotic stewardship programme were small or single-centre.
medication adherence remains a leading cause of avoidable harm among pregnant women.
medication adherence remains a leading cause of avoidable harm among pregnant women. The cost of medication adherence to health systems is substantial. Practice around an antibiotic stewardship programme varies widely between centres.
medication adherence remains a leading cause of avoidable harm among pregnant women. Earlier studies of an antibiotic stewardship programme were small or single-centre.
Discussion
These findings suggest that an antibiotic stewardship programme is associated with better medication adherence in pregnant women. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
Residual confounding cannot be excluded. These findings suggest that an antibiotic stewardship programme is associated with better medication adherence in pregnant women. Strengths include the sample size and blinded outcome assessment.
Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that an antibiotic stewardship programme is associated with better medication adherence in pregnant women. Residual confounding cannot be excluded.
Conclusions
An antibiotic stewardship programme should be considered for pregnant women to improve medication adherence.
References
1. Silva T, Mueller L, et al. Tranexamic acid and 30-day readmission. JAMA. 2021;138(11):745-1775.
2. Kaur R, Schmidt K, et al. High-flow nasal oxygen and time to diagnosis. Crit Care Med. 2012;104(12):438-904.
3. Mueller L, Novak X, et al. An antibiotic stewardship programme and ventilator-free days. JAMA. 2018;264(9):779-927.
4. Osei J, Schmidt B, et al. Early mobilisation and in-hospital mortality. BMJ. 2025;355(8):857-1505.
5. Ahmed R, Dubois J, et al. Delayed cord clamping and patient satisfaction. BMJ. 2015;233(2):70-1448.
6. Moreau Y, Nakamura E, et al. Tranexamic acid and surgical site infection. Diabetes Care. 2020;293(8):574-1122.
7. Novak Y, Okafor O, et al. Continuous glucose monitoring and surgical site infection. BMJ. 2021;65(2):26-1138.
8. Schmidt I, Tanaka P, et al. A sepsis alert system and post-operative delirium. Pediatrics. 2023;392(1):376-1616.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
We conducted a multicentre observational study across 11 centres between 2020 and 2022. Missing data were handled with multiple imputation.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.
We conducted a multicentre observational study across 10 centres between 2014 and 2021. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.
Results
The adjusted odds ratio was 0.91 (95% CI 0.47 to 0.69). Effects were consistent across prespecified subgroups.
medication adherence occurred in 17% of the intervention group versus 14% of controls. Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Intervention | 26 | 10 | 29.2 | 0.72 | 0.48–1.30 |
| Female | 883 | 38 | 32.1 | 0.83 | 0.29–1.24 |
| Male | 227 | 94 | 25.7 | 0.76 | 0.21–1.0 |
| Centre B | 386 | 8 | 6.5 | 0.68 | 0.58–1.8 |
| Age < 65 | 882 | 107 | 33.8 | 0.56 | 0.24–1.33 |
| Intervention | 325 | 74 | 16.0 | 0.80 | 0.60–1.6 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.

Shown for pregnant women; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
medication adherence occurred in 13% of the intervention group versus 34% of controls. The adjusted odds ratio was 0.54 (95% CI 0.22 to 0.82). medication adherence occurred in 4% of the intervention group versus 21% of controls.